BioGaia

Report Publication Announcement • Jun 26, 2014

Press Release 26 June 2014

BioGaia expands in Eslöv

BioGaia's subsidiary TwoPac will build another production facility in Eslöv. BioGaia will invest about SEK 16 million in the new facility.

TwoPac AB was established in 2002 to develop and manufacture packaging solutions for probiotics. Since June 2013 TwoPac is a wholly owned subsidiary of BioGaia.

TwoPac primarily produces drops but also straws with probiotics. The company is also an important partner for BioGaia in the development of new products. Revenues consist solely of sales to BioGaia.

In 2012 a new production plant in Eslöv was completed. It was mainly financed by loans from BioGaia.

For additional information please contact Peter Rothschild, President, telephone: +46 8 555 293 00

Latest press releases from BioGaia

2014-06-18	BioGaia signs new exclusive agreement in the UK
2014-06-17	BioGaia signs distribution agreement for India
2014-05-07	Annual General Meeting of BioGaia AB

BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 26 June 2014, 3:30 pm CET.

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com